¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"ü"¿¡ ´ëÇÑ ´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÇÑÀÚ
somesthetic sensory
ü°¨°¢
ô÷ÊïÊÆ
somatosensory
ü°¨°¢-
ô÷ÊïÊÆ-
¤Ñ system
ü°¨°¢°è
ô÷ÊïÊÆÍ§
¤Ñ area
ü°¨°¢±¸¿ª
ô÷ÊïÊÆÏ¡æ´
¤Ñ seizure
ü°¨°¢¹ßÀÛ
ô÷ÊïÊÆÛ¡íÂ
¤Ñ distribution
ü°¨°¢ºÐÆ÷
ô÷ÊïÊÆÝÂøÖ
somatosensory c.
ü°¨°¢¼º°ÑÁú, ü°¨°¢¼ºÇÇÁú
ô÷ÊïÊÆàõù«òõ
¤Ñ cortex
ü°¨°¢ÇÇÁú
ô÷àõÊïÊÆù«òõ
coelom
ü°
ô÷Ë·
coelomic v.
ü°¼ÒÆ÷
ô÷Ë·á³øà
accumulation
ü·ù¿ë¾×, °íÀοë¾×, ÃàÀû
ôò׺éÁäû, °íÀÎéÁäû, õëîÝ
cribriform
ü¸ð¾ç-, »ç-
Þè-
cribriform f.
ü¸ð¾ç¿À¸ñ, »ç»ó¿Í
ÞèßÒèÀ
somesthetic c.
ü¼º°¨°¢°ÑÁú, ü¼º°¨°¢ÇÇÁú
ô÷àõÊïÊÆù«òõ
somatic evoked potential t.
ü¼ºÀ¯¹ßÀüÀ§°Ë»ç
ô÷àõë¯Û¡ï³êÈËþÞÛ
´ÙÀ½
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÇÑÀÚ
chromosome a.
¿°»öüÀÌ»ó
æøßäô÷ì¶ßÈ
pituitary a.
³úÇϼöü³ó¾ç
Òàù»á÷ô÷ÒÛåË
antibody a.
Ç×üÈíÂø
ù÷ô÷ýåó·
acceptor
¼ö¿ëü,¹Þ°³
áôé»ô÷,¹Þ°³
acrosome
¼±´Üü, ÷´Üü
àÊÓ®ô÷, ôÓÓ®ô÷
activator
Ȱ¼ºÃ¼, Ȱ¼ºÁ¦, Ȱ¼ºÈÀÎÀÚ
üÀàõô÷, üÀàõð¥, üÀàõûùì×í
adenohypophysis
»ù³úÇϼöü, ¼±³úÇϼöü
àÍÒàù»á÷ô÷
adenohypophysitis
»ù³úÇϼöü¿°, ¼±³úÇϼö¿°
àÍÒàù»á÷ô÷æú
pituitary a.
³úÇϼöü»ùÁ¾, ³úÇϼöü¼±Á¾
Òàù»á÷ô÷àÍðþ
¤Ñ receptor
¾Æµå·¹³¯¸°¼º¼ö¿ëü
¾Æµå·¹³¯¸°¼ºáôé»ô÷
alpha adrenergic blocking a.
¾Æµå·¹³¯¸°¼º ¾ËÆÄ-¼ö¿ëüÂ÷´ÜÁ¦
¾Æµå·¹³¯¸°¼º ¾ËÆÄ-áôé»ô÷ó´Ó¨ð¥
etiologic a.
¿øÀÎü, º´ÀÎü
ê«ì×ô÷, Ü»ì×ô÷
alarm systems
°æº¸Ã¼°è
ÌíÜÃô÷ͧ
algorithm
³í¸®Ã¼°è, ³í¸®È帧, ¿¬»ê¹ý
ÒÕ×âô÷ͧ
alloantibody
µ¿Á¾Ç×ü
ÔÒðúù÷ô÷
´ÙÀ½
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½